This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Amerisafe's (AMSF) Q3 Earnings Surpass on Lower Expenses
by Zacks Equity Research
Reduced expenses and an impressive operational efficiency might aid Amerisafe's (AMSF) Q3.
Amerisafe (AMSF) Q3 Earnings Top Estimates
by Zacks Equity Research
Amerisafe (AMSF) delivered earnings and revenue surprises of 34.67% and -1.17%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Amerisafe (AMSF) Q3 Earnings Preview: What to Expect
by Zacks Equity Research
Amerisafe (AMSF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Advance Auto Parts, Atlas Air Worldwide Holdings, ABIOMED, Archer-Daniels-Midland and Amerisafe
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Advance Auto Parts, Atlas Air Worldwide Holdings, ABIOMED, Archer-Daniels-Midland and Amerisafe
5 of the Best Stocks to Buy for a Resurgent Wall Street
by Tirthankar Chakraborty
As the broader market is ready for a counter-trend bounce, it is the ideal time to bet on stocks that are sound enough to grow in the near term.
Can Amerisafe Grow on the Back of Rising Net Premiums?
by Zacks Equity Research
Amerisafe (AMSF) is well poised to rise on solid net premiums growth.
Amerisafe (AMSF) Down 0.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Amerisafe (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Amerisafe (AMSF) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Amerisafe (AMSF) delivered earnings and revenue surprises of 26.03% and 3.55%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks Poised to Emerge Winners in Q2 Earnings
by Zacks Equity Research
Lower cat loss, pricing gains, increasing interest rate environment and solid capital levels should aid insurers' Q2 earnings.
AIG to Report Q2 Earnings: Is Disappointment in Store?
by Zacks Equity Research
AIG's earnings should suffer from underwriting loss as it is taking several initiatives for business realignment.
Accident and Health Insurers Outlook: High Medical Costs Hurt
by Tanuka De
Accident and Health Insurance industry should benefit from strengthening of economy, fueling demand for workers' compensation insurance. However, increasing medical costs pose a challenge.
Can Nasdaq (NDAQ) Keep Earnings Beat Streak Alive in Q2?
by Zacks Equity Research
Nasdaq's (NDAQ) second quarter is likely to benefit from improvement in trading business.
Will Aflac's (AFL) Earnings Suffer From Weak Japan Revenue?
by Zacks Equity Research
Aflacs (AFL) Q2 earnings set to gain from higher U.S segment revenues, partly offset by lower Japan revenues and high costs.
AMERISAFE & Units Receive Rating Actions From A.M. Best
by Zacks Equity Research
A.M. Best revises the credit ratings of AMERISAFE (AMSF) and its subsidiaries along with updated outlooks.
Unum Group (UNM) Q1 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Unum Group (UNM) Q1 earnings gain traction from higher premiums, stable benefits experience and a lower tax rate.
Amerisafe (AMSF) Q1 Earnings Top Estimates on Lower Expenses
by Zacks Equity Research
Amerisafe's (AMSF) Q1 earning upside was driven by an increase in net investment income and a decline in total expenses.
Why Is AMERISAFE (AMSF) Down 6.6% Since Its Last Earnings Report?
by Zacks Equity Research
AMERISAFE (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Get Rid of Amerisafe (AMSF) Now?
by Zacks Equity Research
It seems to be a wise decision for investors to drop Amerisafe (AMSF) stock considering its negative estimate revision, price depreciation as well as unfavorable Zacks rank.
New Strong Sell Stocks for March 6th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Amerisafe's (AMSF) Q4 Earnings Miss as Revenues Decline
by Zacks Equity Research
Amerisafe's (AMSF) earnings suffer from a decline in revenues and increase in expenses.
Marsh & McLennan (MMC) Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Decent performance across segments is likely to drive Marsh & McLennan's (MMC) fourth-quarter results.
What's in Store for MetLife (MET) This Earnings Season?
by Zacks Equity Research
MetLife's (MET) earnings should be driven by higher contribution from its U.S. EMEA, Latin America businesses, partly offset by lower net income from the Asia unit.
Will Weak Japan Business Hurt Aflac's (AFL) Q4 Earnings?
by Zacks Equity Research
Aflac's (AFL) earnings should see a dent from weak Japan business but be partially aided by strength in its U.S. business.
Will Annuities Unit Aid Lincoln National (LNC) Q4 Earnings?
by Zacks Equity Research
Lincoln National's (LNC) earnings are likely to benefit from higher annuity sales, strong Retirement and Life insurance business.
Aflac (AFL) Hits New 52-Week High: Is More Upside Left?
by Zacks Equity Research
Aflac (AFL) gains on estimated positive impact of tax reform but further upside seems muted.